178 related articles for article (PubMed ID: 23442840)
1. Surveillance for hepatocellular carcinoma in a Medicaid cirrhotic population.
Palmer LB; Kappelman MD; Sandler RS; Hayashi PH
J Clin Gastroenterol; 2013 Sep; 47(8):713-8. PubMed ID: 23442840
[TBL] [Abstract][Full Text] [Related]
2. Racial, social, and clinical determinants of hepatocellular carcinoma surveillance.
Singal AG; Li X; Tiro J; Kandunoori P; Adams-Huet B; Nehra MS; Yopp A
Am J Med; 2015 Jan; 128(1):90.e1-7. PubMed ID: 25116425
[TBL] [Abstract][Full Text] [Related]
3. Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study.
Tran S; Jeong D; Henry L; Cheung RC; Nguyen MH
Am J Gastroenterol; 2021 Sep; 116(9):1885-1895. PubMed ID: 33927125
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular Carcinoma Surveillance Among Cirrhotic Patients With Commercial Health Insurance.
Goldberg DS; Valderrama A; Kamalakar R; Sansgiry SS; Babajanyan S; Lewis JD
J Clin Gastroenterol; 2016 Mar; 50(3):258-65. PubMed ID: 26352107
[TBL] [Abstract][Full Text] [Related]
5. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey.
Chalasani N; Said A; Ness R; Hoen H; Lumeng L
Am J Gastroenterol; 1999 Aug; 94(8):2224-9. PubMed ID: 10445554
[TBL] [Abstract][Full Text] [Related]
6. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
Goldberg DS; Taddei TH; Serper M; Mehta R; Dieperink E; Aytaman A; Baytarian M; Fox R; Hunt K; Pedrosa M; Pocha C; Valderrama A; Kaplan DE
Hepatology; 2017 Mar; 65(3):864-874. PubMed ID: 27531119
[TBL] [Abstract][Full Text] [Related]
7. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
[TBL] [Abstract][Full Text] [Related]
8. Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
Aby E; Phan J; Truong E; Grotts J; Saab S
J Clin Gastroenterol; 2019 Feb; 53(2):142-146. PubMed ID: 29912761
[TBL] [Abstract][Full Text] [Related]
9. Suboptimal surveillance for and knowledge of hepatocellular carcinoma among primary care providers.
McGowan CE; Edwards TP; Luong MU; Hayashi PH
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):799-804. PubMed ID: 25117773
[TBL] [Abstract][Full Text] [Related]
10. [Screening for hepatocellular carcinoma in cirrhotic patients].
Beaugrand M
Gastroenterol Clin Biol; 2000 May; 24(5 Pt 2):B92-4. PubMed ID: 10891771
[No Abstract] [Full Text] [Related]
11. Characteristics of hepatocellular carcinoma in Italy.
Stroffolini T; Andreone P; Andriulli A; Ascione A; Craxi A; Chiaramonte M; Galante D; Manghisi OG; Mazzanti R; Medaglia C; Pilleri G; Rapaccini GL; Simonetti RG; Taliani G; Tosti ME; Villa E; Gasbarrini G
J Hepatol; 1998 Dec; 29(6):944-52. PubMed ID: 9875641
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands.
van Meer S; van Erpecum KJ; Sprengers D; Coenraad MJ; Klümpen HJ; Jansen PL; IJzermans JN; Verheij J; van Nieuwkerk CM; Siersema PD; de Man RA
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):352-9. PubMed ID: 26629867
[TBL] [Abstract][Full Text] [Related]
13. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
Bolondi L; Sofia S; Siringo S; Gaiani S; Casali A; Zironi G; Piscaglia F; Gramantieri L; Zanetti M; Sherman M
Gut; 2001 Feb; 48(2):251-9. PubMed ID: 11156649
[TBL] [Abstract][Full Text] [Related]
14. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
15. Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.
Kim HA; Kim KA; Choi JI; Lee JM; Lee CH; Kang TW; Ku YM; Lee SL; Park YS; Yoon JH; Kim SH; Choi MH
BMC Cancer; 2017 Dec; 17(1):877. PubMed ID: 29268722
[TBL] [Abstract][Full Text] [Related]
16. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting.
Wong CR; Garcia RT; Trinh HN; Lam KD; Ha NB; Nguyen HA; Nguyen KK; Levitt BS; Nguyen MH
Dig Dis Sci; 2009 Dec; 54(12):2712-21. PubMed ID: 19876735
[TBL] [Abstract][Full Text] [Related]
17. Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.
Poh Z; Goh BB; Chang PE; Tan CK
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):638-43. PubMed ID: 25831135
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma screening rates vary by etiology of cirrhosis and involvement of gastrointestinal sub-specialists.
Patwardhan V; Paul S; Corey KE; Mazhar SM; Richter JM; Thiim M; Chung RT
Dig Dis Sci; 2011 Nov; 56(11):3316-22. PubMed ID: 21805170
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.
Singal AG; Tiro J; Li X; Adams-Huet B; Chubak J
J Clin Gastroenterol; 2017 Aug; 51(7):650-655. PubMed ID: 27870642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
